Prof Smith succeeds Professor Doug Hilton AO, who stepped down in August this year after 14 years in the role.
With international scientific research links in Hong Kong, Singapore, Korea, and Africa, and with long-standing connections with Europe and the USA, Prof Smith will bring a distinctly global outlook to take WEHI into a new era.
He has been instrumental in forming alliances between industry and academia and has first-hand experience in founding start-up companies and commercial experience with the pharmaceutical industry in the UK, US and Europe.
Prof Smith is a WEHI alum, having completed his Doctor of Philosophy at WEHI through the University of Melbourne, supervised by former WEHI director, Sir Gustav Nossal AC, and Professor David Tarlinton.
His Bachelor of Medicine and Surgery is from the University of Melbourne and his Doctor of Science is from the University of Cambridge.
Prof Smith was elected as a Fellow of the Academy of Medical Sciences in 2006, to the American Association of Physicians in 2020, and was awarded the Lister Institute Research Prize in 2007.
The Smith Lab at Cambridge University runs an experimental medicine and translational program focused on understanding the mechanisms underlying immune-mediated diseases. Prof Smith is also Director of the Cambridge Institute for Therapeutic Immunology and Infectious Disease.